COO vs. BLCO, ALC, GMAB, ALNY, MOH, ALGN, TEVA, ILMN, LH, and BAX
Should you be buying Cooper Companies stock or one of its competitors? The main competitors of Cooper Companies include Bausch + Lomb (BLCO), Alcon (ALC), Genmab A/S (GMAB), Alnylam Pharmaceuticals (ALNY), Molina Healthcare (MOH), Align Technology (ALGN), Teva Pharmaceutical Industries (TEVA), Illumina (ILMN), Laboratory Co. of America (LH), and Baxter International (BAX). These companies are all part of the "medical" sector.
Bausch + Lomb (NYSE:BLCO) and Cooper Companies (NASDAQ:COO) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, profitability, institutional ownership, valuation, risk, dividends and media sentiment.
Cooper Companies has lower revenue, but higher earnings than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.
Bausch + Lomb presently has a consensus target price of $19.45, suggesting a potential upside of 32.80%. Cooper Companies has a consensus target price of $109.69, suggesting a potential upside of 12.73%. Given Cooper Companies' higher possible upside, equities analysts plainly believe Bausch + Lomb is more favorable than Cooper Companies.
Bausch + Lomb has a beta of 0.47, indicating that its stock price is 53% less volatile than the S&P 500. Comparatively, Cooper Companies has a beta of 0.97, indicating that its stock price is 3% less volatile than the S&P 500.
In the previous week, Cooper Companies had 8 more articles in the media than Bausch + Lomb. MarketBeat recorded 9 mentions for Cooper Companies and 1 mentions for Bausch + Lomb. Cooper Companies' average media sentiment score of 0.83 beat Bausch + Lomb's score of 0.30 indicating that Bausch + Lomb is being referred to more favorably in the media.
11.1% of Bausch + Lomb shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 2.0% of Cooper Companies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Cooper Companies received 584 more outperform votes than Bausch + Lomb when rated by MarketBeat users. Likewise, 66.67% of users gave Cooper Companies an outperform vote while only 38.71% of users gave Bausch + Lomb an outperform vote.
Cooper Companies has a net margin of 7.93% compared to Cooper Companies' net margin of -7.81%. Bausch + Lomb's return on equity of 8.79% beat Cooper Companies' return on equity.
Summary
Cooper Companies beats Bausch + Lomb on 15 of the 18 factors compared between the two stocks.
Get Cooper Companies News Delivered to You Automatically
Sign up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding COO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cooper Companies Competitors List
Related Companies and Tools
